UY25677A1 - Nuevos agentes bacterianos de isoxazolinona - Google Patents

Nuevos agentes bacterianos de isoxazolinona

Info

Publication number
UY25677A1
UY25677A1 UY25677A UY25677A UY25677A1 UY 25677 A1 UY25677 A1 UY 25677A1 UY 25677 A UY25677 A UY 25677A UY 25677 A UY25677 A UY 25677A UY 25677 A1 UY25677 A1 UY 25677A1
Authority
UY
Uruguay
Prior art keywords
isoxazolinone
bacterial agents
new bacterial
new
isoxazolinones
Prior art date
Application number
UY25677A
Other languages
English (en)
Inventor
Lawrence B Snyder Y Zhiz Zheng
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of UY25677A1 publication Critical patent/UY25677A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invención describe derivados de isoxazolina que poseen actividad antibacteriana y son útiles en el tratamiento de enfermedades bacterianas. En forma más particular, se proporcionan nuevas isoxazolinonas (fórmula general ver en solicitud).
UY25677A 1998-08-24 1999-08-24 Nuevos agentes bacterianos de isoxazolinona UY25677A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9757498P 1998-08-24 1998-08-24

Publications (1)

Publication Number Publication Date
UY25677A1 true UY25677A1 (es) 2001-08-27

Family

ID=22264103

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25677A UY25677A1 (es) 1998-08-24 1999-08-24 Nuevos agentes bacterianos de isoxazolinona

Country Status (22)

Country Link
EP (1) EP1107756A4 (es)
JP (1) JP2002523369A (es)
KR (1) KR20010072945A (es)
CN (1) CN1314813A (es)
AR (1) AR020250A1 (es)
AU (1) AU748750B2 (es)
BR (1) BR9913225A (es)
CA (1) CA2341271A1 (es)
CO (1) CO5160266A1 (es)
CZ (1) CZ2001669A3 (es)
HU (1) HUP0103433A3 (es)
ID (1) ID27690A (es)
IL (1) IL141542A0 (es)
NO (1) NO20010916L (es)
NZ (1) NZ509867A (es)
PE (1) PE20001063A1 (es)
PL (1) PL346267A1 (es)
TR (1) TR200100672T2 (es)
TW (1) TW572757B (es)
UY (1) UY25677A1 (es)
WO (1) WO2000010566A1 (es)
ZA (1) ZA200101505B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465456B2 (en) * 2000-06-29 2002-10-15 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
JP2002020366A (ja) * 2000-07-05 2002-01-23 Sumitomo Seika Chem Co Ltd アルキルチオフェニル酢酸類の製造方法
PE20030044A1 (es) * 2000-11-17 2003-02-09 Upjohn Co Isoxazolinonas biciclicas de formula i
PE20020689A1 (es) 2000-11-17 2002-08-03 Upjohn Co Oxazolidinonas con un heterociclo de 6 o 7 miembros unidos con enlace anular al benceno
US6861433B2 (en) * 2000-12-15 2005-03-01 Pharmacia & Upjohn Company Oxazolidinone photoaffinity probes
ATE319710T1 (de) 2000-12-21 2006-03-15 Pharmacia & Upjohn Co Llc Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
ES2180456B1 (es) * 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
JP2005512975A (ja) 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体
US6875784B2 (en) 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
CA2499105A1 (en) 2002-10-10 2004-04-22 Pharmacia & Upjohn Company Llc Antimicrobial 1-aryl dihydropyridone compounds
CA2515311A1 (en) * 2003-02-07 2004-08-19 Warner-Lambert Company Llc Antibacterial agents
EP1620098B1 (en) 2003-04-30 2008-06-11 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
JP5043428B2 (ja) 2003-06-03 2012-10-10 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ビアリール複素環式化合物ならびにその製造および使用方法
WO2005070904A2 (en) * 2003-06-03 2005-08-04 Rib-X Pharmaceutical, Inc. Sulfonamide compounds and methods of making and using the same
WO2005012270A2 (en) * 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same
DE10340485B4 (de) * 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
AR046782A1 (es) 2003-12-17 2005-12-21 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
DE602004015158D1 (de) 2003-12-18 2008-08-28 Morphochem Ag Komb Chemie Oxazolidinon-chinolon hybrid antibiotika
WO2005082900A2 (en) * 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone amidoximes as antibacterial agents
KR101394307B1 (ko) 2005-06-08 2014-05-13 멜린타 테라퓨틱스, 인크. 트리아졸의 합성 방법
AT503354B1 (de) * 2006-02-22 2008-07-15 Dsm Fine Chem Austria Gmbh Verfahren zur herstellung von 3,4-disubstituierten phenylessigsäuren, sowie neue zwischenverbindungen
JP4518066B2 (ja) * 2006-10-25 2010-08-04 宇部興産株式会社 ジアルコキシニトリル誘導体及びその製法
CN110423610B (zh) * 2019-08-29 2023-05-12 浙江理工大学 一种检测双光子汞离子荧光探针及其制备方法与使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2045049A1 (de) * 1970-09-11 1972-03-23 Dr Karl Thomae GmbH, 7950 Biberach Neue Nitrofurandenvate und Ver fahren zu ihrer Herstellung
US4000155A (en) * 1975-12-11 1976-12-28 Eli Lilly And Company Herbicidal 2-methyl-4-phenyl-5-pyrazolinones[and isoxazolinones]
ATE161833T1 (de) * 1992-12-08 1998-01-15 Upjohn Co Durch eine tropon gruppe substituierte phenyloxazolidinone-derivate als antibakterielles mittel
AU6902096A (en) * 1995-09-15 1997-04-01 Pharmacia & Upjohn Company 5-amidomethyl alpha, beta-saturated and -unsaturated 3-aryl butyrolactone antibacterial agents
GB9521508D0 (en) * 1995-10-20 1995-12-20 Zeneca Ltd Chemical compounds
DE69716925T2 (de) * 1996-08-21 2003-09-11 Upjohn Co Isoxazoline derivate und ihre verwendung als antimikroben

Also Published As

Publication number Publication date
KR20010072945A (ko) 2001-07-31
AR020250A1 (es) 2002-05-02
CO5160266A1 (es) 2002-05-30
ID27690A (id) 2001-04-19
NZ509867A (en) 2003-08-29
CN1314813A (zh) 2001-09-26
AU748750B2 (en) 2002-06-13
TW572757B (en) 2004-01-21
EP1107756A4 (en) 2003-02-26
HUP0103433A2 (hu) 2002-01-28
CA2341271A1 (en) 2000-03-02
BR9913225A (pt) 2001-05-22
NO20010916L (no) 2001-04-10
PE20001063A1 (es) 2000-12-24
AU5783399A (en) 2000-03-14
IL141542A0 (en) 2002-03-10
JP2002523369A (ja) 2002-07-30
PL346267A1 (en) 2002-01-28
TR200100672T2 (tr) 2001-07-23
EP1107756A1 (en) 2001-06-20
HUP0103433A3 (en) 2002-08-28
WO2000010566A1 (en) 2000-03-02
ZA200101505B (en) 2002-02-22
CZ2001669A3 (cs) 2001-08-15
NO20010916D0 (no) 2001-02-23

Similar Documents

Publication Publication Date Title
UY25677A1 (es) Nuevos agentes bacterianos de isoxazolinona
UY26380A1 (es) Inhibidores de fab i
AU2003291227A8 (en) Antibacterial agents
TW200507841A (en) Antibacterial agents
WO2004058144A3 (en) Antibacterial agents
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
EP1560821B8 (en) Antibacterial agents
ECSP055823A (es) DERIVADOS DE [6,7-DIHIDRO-5H-IMIDAZO[1,2-a]IMIDAZOL-3-SULFONILAMINO]-PROPIONAMIDA
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
AU2003294565A8 (en) Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
DE50310323D1 (de) Wässrige polyurethanzubereitungen
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
BR0307085A (pt) Terapia combinada para o tratamento de infecções bacterianas
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
NO20005548D0 (no) Mykobakterieinhibitorer
DE60201440D1 (de) Aryl-8-azabicyclo[3.2.1]octanes für die behandlung von depression
BRPI0413744A (pt) n-aril-2-ciano-oxazolidinonas e seus derivados
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
ECSP993109A (es) Nuevos agentes antibacterianos de isoxazolinona
MXPA05009243A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados.
ATE478155T1 (de) Glycopeptidantibiotika
DK1133297T3 (da) Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin
DE60235538D1 (de) Glycopeptid-antibiotika

Legal Events

Date Code Title Description
ABAN Application deemed to be withdrawn (no publication fee paid)

Effective date: 20090609